You are here

Article info

Article menu
Download PDFPDF
Commentary
Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?

Authors

  1. Correspondence to Professor Mark Thursz, Hepatology & Gastroenterology, Imperial College, Norfolk Place, London W2 1NY, UK; m.thursz{at}imperial.ac.uk
View Full Text

Citation

Thursz M, Brown A
Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
Gut 2011;60:1025-1026.

Publication history

  • First published April 20, 2011.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.